Format

Send to

Choose Destination
Neurotherapeutics. 2015 Jan;12(1):126-31. doi: 10.1007/s13311-014-0335-5.

A systems approach to drug discovery in Alzheimer's disease.

Author information

1
Department of Pathology and Cell Biology, Columbia University, New York, NY, 10032, USA, mls7@columbia.edu.

Abstract

In the articles included in this volume, one feels a strong frustration among the writers with the slow course of therapeutics development for Alzheimer's disease and with the clinical failure of targeted therapeutic agents despite substantial progress in our understanding of the biology and biochemistry of the disease.

PMID:
25608936
PMCID:
PMC4322083
DOI:
10.1007/s13311-014-0335-5
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center